Futura Medical Transforms Leadership Amid Share Price Woes
Company - People | Jul 08, 2025 | Business Cloud
Futura Medical plc, a Surrey-based listed MedTech company specializing in sexual health products, has undergone a significant leadership change following a downturn in share prices. The decision emerged after extensive discussions between the board and its largest shareholder, resulting in the resignation of non-executive chair Jeff Needham and CEO James Barder. Alex Duggan is set to step in as Interim CEO, bringing a vast experience in consumer healthcare and a track record of scaling global businesses. Duggan's appointment, effective in early August pending due diligence checks, marks a critical shift in leadership aimed at reshaping the company's strategy to enhance shareholder value and commercial prospects. Duggan will primarily focus on reviewing current business operations and strategies around Futura's flagship product, Eroxon, a clinically validated sexual health solution. The company, which floated in 2003, has seen its share price drop to 8.11p from an initial 73.08p, flagged by a market cap of £25.29 million, underscoring the urgency for revitalized leadership and strategy.
Sectors
- MedTech
- Healthcare
- Consumer Goods
Geography
- United Kingdom – Futura Medical is a Surrey-based company and the developments pertain to changes in its leadership and strategy.
- Europe – Alex Duggan’s career includes operations across Europe, indicating a geographical span relevant to his experience.
Industry
- MedTech – The article centers around Futura Medical, a company involved in the development and commercialization of medical technology products, particularly in the sexual health sector.
- Healthcare – Relevant due to Alex Duggan’s extensive background in consumer healthcare and the prescription sectors.
- Consumer Goods – Futura Medical's focus on products with global consumer appeal highlights the relevance of the consumer goods industry.
Financials
- 25.29m – Futura Medical's market capitalization.
- 8.11p – Current share price of Futura Medical.
- 73.08p – Initial flotation share price of Futura Medical in 2003.
- 31.43p – Share price as of the beginning of 2025.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Futura Medical plc | Target | Company | A Surrey-based MedTech company involved in developing and commercializing sexual health products. |
| Jeff Needham | Non-executive Chair | Person | Former chairperson, who resigned amid calls for new leadership. |
| James Barder | CEO | Person | Outgoing CEO who played a significant role in building the business over a long period. |
| Alex Duggan | Interim CEO | Person | Appointed as Interim CEO with a strong background in healthcare and experience in scaling global businesses. |
| Alliance Pharmaceuticals | Commercial Role | Company | Duggan's previous employer, where he served as chief commercial & corporate development officer. |
| Proprietary Association of Great Britain | Board Member | Company | One of the boards Alex Duggan has served on, indicating his significant industry experience. |